Security key
501147102
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS)
CUSIP: 501147102
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, $0.00001 par value ("Common Stock")
- Total 13F shares
- 20,979,177
- Total 13F value
- $1,678,957,589
- Share change
- +121,784
- Put/Call ratio
- 180%
- SEC-reported price per share
- $80.06
- Number of holders
- 159
- Value change
- +$9,326,151
- Number of buys
- 75
- Number of sells
- 65
- Shares outstanding
- 29,463,330
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q1 2023
Institutions
159
Top holders
10
KRYS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2023
Previous quarter: Q4 2022
Krystal Biotech, Inc. SEC filings
Krystal Biotech, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501147102
Recent filing periods:
Ownership snapshot
Top reported holders of KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
Lead comparable stake: 7.2%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 7.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
FMR LLC
7.2%
Redmile Group, LLC
6.4%
BlackRock Finance, Inc.
5.8%
Avoro Capital Advisors LLC
4.8%
LORD, ABBETT & CO. LLC
4.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
7.2%
|
$167,063,335
2,108,853 shares
|
— | 31 Dec 2022 |
| Redmile Group, LLC |
13F
Company
|
6.4%
|
$150,252,217
1,896,645 shares
|
— | 31 Dec 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
5.8%
|
$134,641,998
1,699,596 shares
|
— | 31 Dec 2022 |
| Avoro Capital Advisors LLC |
13F
Company
|
4.8%
|
$111,700,200
1,410,000 shares
|
— | 31 Dec 2022 |
| LORD, ABBETT & CO. LLC |
13F
Company
|
4.3%
|
$101,245,000
1,278,022 shares
|
— | 31 Dec 2022 |
| VANGUARD GROUP INC |
13F
Company
|
4%
|
$94,122,075
1,188,110 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
159
Shares
20,979,177
Rows available
159
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
153
Q1 2023 holders
159
Holder diff
6
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend